Safinamide inhibition of in vivo glutamate release in a rat model of Parkinson's Disease

被引：0
|
作者：
Padoani, G.
Novello, S.
Pisano, C.
Caccia, C.
Melloni, E.
Vailati, S.
Keywood, C.
Morari, M.
机构：
来源：
MOVEMENT DISORDERS | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
182
引用
收藏
页码：S81 / S82
页数：2
相关论文
共 50 条
  • [21] Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease
    Farrand, Ariana Q.
    Gregory, Rebecca A.
    Backman, Cristina M.
    Helke, Kristi L.
    Boger, Heather A.
    BRAIN RESEARCH, 2016, 1651 : 88 - 94
  • [22] Effects of safinamide in patients with Parkinson's disease measured by Parkinson's KinetiGraphTM
    Suttrup, I.
    Zentsch, V.
    Schroeder, J.
    Warnecke, T.
    MOVEMENT DISORDERS, 2016, 31 : S623 - S623
  • [23] The resurgence of neurotransmitter modulation in Parkinson's disease with safinamide
    Mueller, Thomas
    JOURNAL OF PARKINSONISM AND RESTLESS LEGS SYNDROME, 2015, 5 : 11 - 17
  • [24] Addition of Opicapone to Safinamide in Parkinson's Disease patients
    Russo, M.
    Carrarini, C.
    Dono, F.
    Di Pietro, M.
    Rispoli, M.
    Ferri, L.
    Onofrj, M.
    MOVEMENT DISORDERS, 2019, 34 : S80 - S80
  • [25] SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease
    Gomez-Lopez, Ana
    Sanchez-Sanchez, Arantxa
    Natera-Villalba, Elena
    Ros-Castello, Victoria
    Beltran-Corbellini, Alvaro
    Fanjul-Arbos, Samira
    Parees Moreno, Isabel
    Lopez-Sendon Moreno, Jose Luis
    Martinez Castrillo, Juan Carlos
    Alonso-Canovas, Araceli
    BRAIN SCIENCES, 2021, 11 (01) : 1 - 8
  • [26] NMDA-metabotropic glutamate receptors interaction in a rat model of Parkinson's disease
    Breysse, N
    Amalric, M
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S75 - S75
  • [27] Association of Cognitive Deficit with Glutamate and Insulin Signaling in a Rat Model of Parkinson's Disease
    Knezovic, Ana
    Piknjac, Marija
    Barilar, Jelena Osmanovic
    Perhoc, Ana Babic
    Virag, Davor
    Homolak, Jan
    Salkovic-Petrisic, Melita
    BIOMEDICINES, 2023, 11 (03)
  • [28] Effects of safinamide and rasagiline on in vivo glutamate release in 6-OHDA hemilesioned rats
    Pisano, C. A.
    Brugnoli, A.
    Novello, S.
    Caccia, C.
    Keywood, C.
    Melloni, E.
    Padoani, G.
    Vailati, S.
    Morari, M.
    MOVEMENT DISORDERS, 2019, 34 : S144 - S144
  • [29] Safinamide reduces membrane excitability and synaptic transmission of striatal spiny projection neurons in a rat model of Parkinson's disease
    Tozzi, A.
    Sciaccaluga, M.
    Mazzocchetti, P.
    Bastioli, G.
    Ghiglieri, V.
    Picconi, B.
    Caccia, C.
    Keywood, C.
    Padoani, G.
    Calabresi, P.
    MOVEMENT DISORDERS, 2019, 34 : S146 - S146
  • [30] Safinamide for pain management in patients with Parkinson's disease
    Abilashimova, D.
    Aubakirova, M.
    Abdildin, Y.
    Viderman, D.
    REVUE NEUROLOGIQUE, 2025, 181 (1-2) : 11 - 20
12345